Detalles de la búsqueda
1.
Trial of Solanezumab in Preclinical Alzheimer's Disease.
N Engl J Med
; 389(12): 1096-1107, 2023 Sep 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-37458272
2.
Amyloid-Related Imaging Abnormalities in the DIAN-TU-001 Trial of Gantenerumab and Solanezumab: Lessons from a Trial in Dominantly Inherited Alzheimer Disease.
Ann Neurol
; 92(5): 729-744, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36151869
3.
Targeting amyloid ß in Alzheimer's disease: Meta-analysis of low-dose solanezumab in Alzheimer's disease with mild dementia studies.
Alzheimers Dement
; 19(10): 4619-4628, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36946603
4.
Statistical properties of continuous composite scales and implications for drug development.
J Biopharm Stat
; 27(6): 1104-1114, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28402165
5.
Downstream Biomarker Effects of Gantenerumab or Solanezumab in Dominantly Inherited Alzheimer Disease: The DIAN-TU-001 Randomized Clinical Trial.
JAMA Neurol
; 81(6): 582-593, 2024 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38683602
6.
Magnetic resonance imaging measures of brain volumes across the EXPEDITION trials in mild and moderate Alzheimer's disease dementia.
Alzheimers Dement (N Y)
; 8(1): e12313, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35783453
7.
Avoid or Embrace? Practice Effects in Alzheimer's Disease Prevention Trials.
Front Aging Neurosci
; 14: 883131, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35783127
8.
Evaluation of dose-dependent treatment effects after mid-trial dose escalation in biomarker, clinical, and cognitive outcomes for gantenerumab or solanezumab in dominantly inherited Alzheimer's disease.
Alzheimers Dement (Amst)
; 14(1): e12367, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36348972
9.
A novel approach to delayed-start analyses for demonstrating disease-modifying effects in Alzheimer's disease.
PLoS One
; 10(3): e0119632, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25781335
10.
Delayed-start analysis: Mild Alzheimer's disease patients in solanezumab trials, 3.5 years.
Alzheimers Dement (N Y)
; 1(2): 111-121, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-29854931
11.
Characteristics and mortality among hospitalized patients treated with intramuscular antipsychotics: analysis of a United States hospital database.
Curr Drug Saf
; 5(3): 203-11, 2010 Jul 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-20210728
12.
The effect of pharmacotherapy for attention deficit hyperactivity disorder on risk of seizures in pediatric patients as assessed in an insurance claims database.
Curr Drug Saf
; 3(2): 123-31, 2008 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-18690990
Resultados
1 -
12
de 12
1
Próxima >
>>